S.Amdt. 4023

SA 4023. Mrs. SHAHEEN submitted an amendment intended to be proposed
to amendment SA 3867 submitted by Mr. Reed and intended to be proposed
to the bill H.R. 4350, to authorize appropriations for fiscal year 2022
for military activities of the Department of Defense, for military
construction, and for defense activities of the Department of Energy,
to prescribe military personnel strengths for such fiscal year, and for
other purposes; which was ordered to lie on the table; as follows:

At the end of subtitle C of title VII, add the following:

SEC. 744. INCLUSION OF EXPOSURE TO PERFLUOROALKYL AND
POLYFLUOROALKYL SUBSTANCES AS COMPONENT OF
PERIODIC HEALTH ASSESSMENTS.

(a) Periodic Health Assessment.--Each Secretary concerned
shall ensure that any periodic health assessment provided to
a member of the Armed Forces includes an assessment of
whether the member has been--
(1) based or stationed at a military installation
identified by the Secretary concerned as a location with a
known or suspected release of perfluoroalkyl substances or
polyfluoroalkyl substances during the period in which the
member was based or stationed at the military installation;
or
(2) exposed to such substances, including by assessing any
information in the health record of the member.
(b) Separation History and Physical Examinations.--Section
1145(a)(5) of title 10, United States Code, is amended by
adding at the end the following new subparagraph:
``(D) The Secretary concerned shall ensure that each
physical examination of a member under subparagraph (A)
includes an assessment of whether the member was--
``(i) based or stationed at a military installation
identified by the Secretary concerned as a location with a
known or suspected release of perfluoroalkyl substances or
polyfluoroalkyl substances during the period in which the
member was based or stationed at the military installation;
or
``(ii) exposed to such substances, including by assessing
any information in the health record of the member.''.
(c) Deployment Assessments.--Section 1074f(b)(2) of title
10, United States Code, is amended by adding at the end the
following new subparagraph:
``(E) An assessment of whether the member was--
``(i) based or stationed at a military installation
identified by the Secretary concerned as a location with a
known or suspected release of perfluoroalkyl substances or
polyfluoroalkyl substances during the period in which the
member was based or stationed at the military installation;
or
``(ii) exposed to such substances, including by assessing
any information in the health record of the member.''.
(d) Provision of Blood Testing to Determine Exposure to
Perfluoroalkyl Substances or Polyfluoroalkyl Substances.--
(1) In general.--If a covered evaluation of a member of the
Armed Forces results in a positive determination of potential
exposure to perfluoroalkyl substances or polyfluoroalkyl
substances, the Secretary concerned shall provide to that
member, during the covered evaluation, blood testing to
determine and document potential exposure to such substances.
(2) Inclusion in health record.--The results of a blood
test of a member of the Armed Forces conducted under
subparagraph (A) shall be included in the health record of
the member.
(e) Definitions.--In this section:
(1) Covered evaluation.--The term ``covered evaluation''
means--
(A) a periodic health assessment conducted in accordance
with subsection (a);
(B) a separation history and physical examination conducted
under section 1145(a)(5) of title 10, United States Code, as
amended by subsection (b); or
(C) a deployment assessment conducted under section
1074f(b)(2) of such title, as amended by subsection (c).
(2) Secretary concerned.--The term ``Secretary concerned''
has the meaning given such term in section 101 of title 10,
United States Code.
______